milrinone has been researched along with omega-n-methylarginine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
Ikeda, M; Kawase, T; Matsumoto, S; Nishikawa, T; Takahashi, T; Yoshida, S | 1 |
Eisenach, JH; Elvebak, RL; Joyner, MJ; Nicholson, WT | 1 |
1 trial(s) available for milrinone and omega-n-methylarginine
Article | Year |
---|---|
The function of vascular smooth muscle phosphodiesterase III is preserved in healthy human aging.
Topics: Aged; Aging; Blood Vessels; Cyclic Nucleotide Phosphodiesterases, Type 3; Epoprostenol; Female; Health; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Muscle, Smooth, Vascular; Nitroprusside; omega-N-Methylarginine; Vasodilation | 2010 |
2 other study(ies) available for milrinone and omega-n-methylarginine
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Effects of N(G)-monomethyl-L-arginine on Ca(2+) current and nitric-oxide synthase in rat ventricular myocytes.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Animals; Calcium Channels, L-Type; Colforsin; Cyclic GMP; Enzyme Inhibitors; Milrinone; NADPH Dehydrogenase; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Rats | 2000 |